Cinema8
CAMBRIDGE, ENGLAND / ACCESSWIRE / February 20, 2024 / Cinema8, the innovative AI-core video experience platform, is thrilled to announce a strategic partnership with Dailymotion, a leader in video solution services. The partnership is set to revolutionise the digital media industry by adding interactivity to videos on Dailymotion's cutting-edge video technology.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Cinema8 has been at the forefront of redefining video engagement, specialising in transforming passive viewing into dynamic, interactive experiences. The platform offers a diverse range of tools to enhance viewer engagement through its AI-core technology. Features like AI-generated subtitles with translations in over 100 languages, automating video management tasks like SEO-compatible video summarisation, and innovative interactivity options with over 1,000 ready-to-use widgets position Cinema8 as a key player in the digital video strategy domain.
This collaboration is expected to bring a wealth of benefits to both Dailymotion and Cinema8. By partnering with Cinema8, Dailymotion can offer interactive video player enabling enterprises to maximize their return on investment and reach their engagement goals, particularly in e-learning, video marketing, and corporate communications. Cinema8's array of interactive features, such as gamification, personalization, and shoppable elements, as well as its video creation tools like screen recording and video editing, will now be available to a broader customer through Dailymotion.
Mr. Alisan Erdemli, CEO of Cinema8, expresses his enthusiasm about the partnership: "With our recent partnership and integration features, we're excited to bring the limitless engagement power of interactive videos to Dailymotion customers. Interactive experiences are the future of viewing, and I'm looking forward to making streaming smarter a success with Dailymotion."
Remi Leclancher, VP Partnerships in EMEA at Dailymotion commented on the partnership, "This collaboration with Cinema8 represents a significant step in our ongoing effort to enhance the digital video experience for our customers. Cinema8's innovative approach to interactive content aligns with our vision of helping enterprises achieve their goals through cutting-edge video solutions."
Cinema8 and Dailymotion both remain committed to pushing the boundaries of digital video solutions. This partnership not only symbolises a key development for both organisations but also heralds a new era of interactive video content, promising to redefine viewer engagement in the digital age.
Find out more about our interactive video solutions.
Contact us for more information.
Contact Information:
Cinema8 Media Relations
Contact Name: Rosan Erdemli
Phone Number: +44 20 3318 6011
Email Address: info@cinema8.com
Website: https://cinema8.com/
Follow us on
https://www.linkedin.com/company/cinema8/
https://twitter.com/cinema8official
https://www.facebook.com/Cinema8official
https://www.instagram.com/cinema8.official/
https://www.youtube.com/c/Cinema8official
SOURCE: Cinema8
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
PromiCell, Inc. presents during JP Morgan's 2026 Healthcare Conference9.1.2026 18:35:00 CET | Press release
MIAMI, FL / ACCESS Newswire / January 9, 2026 / PromiCell, Inc. (the "Company"), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell therapies for cancer patients, today announced that the Company's Chief Medical Officer, John Lee, MD, Ph.D., will present interim results of the Company's lead asset PRO CAR - 201A, a STEAP1 directed CAR T cell that is currently in the clinic as a first-in-human phase 1 trial for the treatment of metastatic castration-resistant prostate cancer (mCRPC), at Biotech Showcase 2026 in San Francisco, California on Monday, January 12, 2025 at 11:15 am PST at the Franciscan D (Ballroom Level). About PromiCell, Inc. PromiCell, is a clinical-stage cellular immunotherapy company with product candidates representing highly differentiated and novel CAR T and TCR T platforms to be developed across separate solid and hematologic types of cancer. Our pipeline of innovative products includes STEAP 1 CAR T cells, HA-1 T
Datavault AI Expands IBM Collaboration to Deploy Enterprise-Grade AI at the Edge with Available Infrastructure's SanQtum AI Platform8.1.2026 13:00:00 CET | Press release
Datavault AI will activate a secured multi-city edge AI network for real-time data tokenization, security, and monetization across New York and Philadelphia NEW YORK, NY / ACCESS Newswire / January 8, 2026 / Datavault AI Inc. (Nasdaq:DVLT), a leader in instant data monetization & enterprise digital twins, announced it will deliver enterprise-grade AI performance at the edge in New York and Philadelphia through an expanded collaboration with IBM using the SanQtum AI platform. Operated by Available Infrastructure, SanQtum AI is a fleet of synchronized micro edge data centers running IBM's watsonx portfolio of AI products on a zero-trust network. The combined deployment is designed to enable cybersecure data storage and compute, real-time data scoring, tokenization, and ultra-low-latency, across two of the most data-dense metro regions in the United States. By running Datavault AI's Information Data Exchange and DataScore agents - built with watsonx - within SanQtum AI's zero-trust edge e
Ascend Advanced Therapies - ABL Inc. Further Strengthens Executive Team as It Drives Forward an Ambitious Growth Strategy8.1.2026 13:00:00 CET | Press release
Seiga Ohmine to join as Chief Commercial Officer, Sharad Dubey as Chief Financial Officer and Patrick Lansky as Senior Vice President of Global Business Development Appointments underscore Ascend-ABL's commitment to scientific rigor, operational excellence, and strategic growth ROCKVILLE, MARYLAND / ACCESS Newswire / January 8, 2026 / Ascend Advanced Therapies - ABL Inc. today announced significant appointments to its leadership team. Seiga Ohmine Ph.D. joins as Chief Commercial Officer (CCO) Sharad Dubey CA, CPA joins as Chief Financial Officer (CFO) Patrick Lansky joins as Senior Vice President of Global Business Development These appointments reflect Ascend-ABL's focus on strengthening scientific leadership, operational discipline, and customer-centric execution as the company sharpens its positioning as a trusted CDMO partner for advanced viral modalities. Commenting on the appointments, Alessandra Rispoli, Chief Executive Officer of Ascend-ABL said, "We are making strong progress
Market Logic Announces Technology Partnership with Zappi to Accelerate Innovation with AI8.1.2026 08:00:00 CET | Press release
BERLIN, DE / ACCESS Newswire / January 8, 2026 / Market Logic Software is excited to announce a technology partnership with Zappi designed to help leading brands develop, refine, and test new product concepts faster than ever before. United by a joint agentic AI framework, this collaboration brings together advanced AI capabilities from both companies, marking a pivotal shift in how organizations execute insights-driven innovation. Through AI-to-AI integrations, linking two powerful AI platforms, enterprises can now enrich their product innovation process with a comprehensive data ecosystem. Specially trained DeepSights AI agents within Market Logic's Innovation Studio continuously monitor, analyse, and synthesize market research, news, and operational data-allowing for accelerated concept generation and more informed decision-making. With just a couple of clicks, customers can seamlessly progress to testing their concepts with real people, thanks to Zappi's real-world respondent solut
RE Royalties Announces up to a USD $9.0 Million Portfolio-Level Royalty Investment with Solaris Energy Inc.7.1.2026 22:20:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / January 7, 2026 / RE Royalties Ltd. (TSXV:RE)(OTCQX:RROYF) ("RE Royalties" or the "Company") is pleased to announce that it has entered into a definitive agreement with Solaris Energy Inc. ("Solaris") to invest up to USD $9.0 million to acquire a royalty interest (the "Royalty Purchase") in two portfolios of distributed generation ("DG") solar projects located throughout the United States. The first portfolio consists of 15 projects including 9 under construction with several nearing operation, and 6 in development, located across California, Maine, Delaware, New Hampshire and Colorado ("Portfolio 1"). The second portfolio comprises 9 more projects, the final composition of which may evolve as the projects advance ("Portfolio 2"). The transaction represents the acquisition of a portfolio level royalty on a diversified portfolio of DG solar assets and marks the exciting beginning of a new partnership between the two parties. The Royalty Purchase for Por
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom